North America Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: February 20, 2026 Report Code: GDME21685CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Glucose Monitoring Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Continuous Glucose Monitors

The North America Glucose Monitoring Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Glucose Monitoring Market.
• Global corporate-level profiles of key companies operating within the North America Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Glucose Monitoring is segmented as follows:_x000D_

• Continuous Glucose Monitors

Reasons to Buy

The North America Glucose Monitoring Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories
DexCom Inc
Medtronic Plc

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Glucose Monitoring Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Glucose Monitoring Market, North America

3.1 Glucose Monitoring Market, North America, Revenue ($m), 2018-2033

3.2 Glucose Monitoring Market, North America, Revenue ($m), 2018-2033

3.3 Glucose Monitoring Market, North America, Volume (Units), 2018-2033

3.4 Glucose Monitoring Market, North America, Volume (Units), 2018-2033

3.5 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2025

4 Glucose Monitoring Market, Canada

4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2018-2033

4.1.1 Continuous Glucose Monitors Market, Canada, Revenue ($m), by Segment, 2018-2033

4.2 Glucose Monitoring Market, Canada, Volume (Units), 2018-2033

4.2.1 Continuous Glucose Monitors Market, Canada, Volume (Units), by Segment, 2018-2033

4.3 Glucose Monitoring Market, Canada, Average Price ($), 2018-2033

4.4 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2025

5 Glucose Monitoring Market, Mexico

5.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2018-2033

5.1.1 Continuous Glucose Monitors Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.2 Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033

5.2.1 Continuous Glucose Monitors Market, Mexico, Volume (Units), by Segment, 2018-2033

5.3 Glucose Monitoring Market, Mexico, Average Price ($), 2018-2033

5.4 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2025

6 Glucose Monitoring Market, United States

6.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033

6.1.1 Continuous Glucose Monitors Market, United States, Revenue ($m), by Segment, 2018-2033

6.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033

6.2.1 Continuous Glucose Monitors Market, United States, Volume (Units), by Segment, 2018-2033

6.3 Glucose Monitoring Market, United States, Average Price ($), 2018-2033

6.4 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025

7 Overview of Key Companies in North America Glucose Monitoring Market

7.1 Abbott Laboratories

7.1.1 Company Overview

7.2 DexCom Inc

7.2.1 Company Overview

7.3 Medtronic Plc

7.3.1 Company Overview

8 Glucose Monitoring Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications

9.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work

9.1.2 Nov 18, 2025: Dedicated Platelet Donor Discovers Health Benefits of A1C Testing

9.1.3 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors

9.1.4 Oct 29, 2025: Glucotrack Appoints Usman Latif, MD, MBA, to Clinical Advisory Team

9.1.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment

9.1.6 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

9.1.7 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

9.1.8 Apr 23, 2025: Biolinq raises $100m to support US launch of intradermal glucose sensor

9.1.9 Feb 19, 2025: Thermo Fisher Scientific Elects New Director to Board

9.1.10 Jan 21, 2025: Glucotrack Announces ISO 13485:2016 Certification

9.2 Financial Announcements

9.2.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results

9.2.2 Oct 22, 2025: Senseonics Holdings Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

9.2.3 Oct 06, 2025: Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

9.2.4 Aug 06, 2025: Senseonics Holdings Announces Results for Q2 Ended June 30, 2025

9.2.5 Jul 01, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025

9.2.6 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results

9.2.7 Mar 03, 2025: Senseonics Holdings Reports Fourth Quarter and Full Year 2024 Financial Results

9.2.8 Jan 02, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025

9.3 Government and Public Interest

9.3.1 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

9.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract

9.3.3 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

9.3.4 Feb 24, 2025: Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025

9.3.5 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference

9.3.6 Jan 07, 2025: New Publication Highlights Safety and Potential Benefits of Redosing Diamyd Precision Medicine for Type 1 Diabetes

9.3.7 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo

9.3.8 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

9.4 Other Significant Developments

9.4.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results

9.4.2 Oct 27, 2025: Lifescan Receives Court Approval of Plan of Reorganization

9.4.3 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS

9.4.4 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)

9.4.5 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program

9.4.6 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes

9.4.7 Dec 20, 2024: Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

9.5 Product News

9.5.1 Nov 20, 2025: Stanley Hsia, MD, Presents Phase 2 Trial Results for Mazdutide

9.5.2 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes

9.5.3 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation

9.5.4 Nov 10, 2025: Senseonics Holdings To Participate in the Stifel 2025 Healthcare Conference

9.5.5 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems

9.5.6 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results

9.5.7 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches

9.5.8 Oct 14, 2025: OSR Holdings Enters Agreement to Acquire Woori IO for Noninvasive Glucose Monitoring Technology

9.5.9 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment

9.5.10 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment

9.5.11 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes

9.5.12 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes

9.5.13 Jul 10, 2025: Wristband Sensor Provides All-in-one Monitoring for Diabetes and Cardiovascular Care

9.5.14 Apr 28, 2025: Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics

9.5.15 Mar 03, 2025: High School Junior Max Kopp is Pioneering the Future of Wearable Technology, Championed by Crown Wealth

9.5.16 Jan 06, 2025: Introducing isaac by PreEvnt – Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit

9.6 Strategy And Business Planning

9.6.1 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems

9.6.2 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results

9.6.3 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches

9.6.4 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS

9.6.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment

9.6.6 Oct 16, 2025: Thermo Fisher Scientific To Accelerate Life Science Breakthroughs With OpenAI

9.6.7 Sep 23, 2025: Glooko Acquires Monarch Medical Technologies to Broaden Diabetes Care Solutions

9.6.8 Sep 17, 2025: Hackensack Meridian Health Launches Your Health On The Move Initiative for Free Health Screenings in New Jersey

9.6.9 May 19, 2025: Actinogen CMO Presents Positive Depression Trial Data at the American Psychiatric Association 2025 Annual Meeting

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Market Modeling and Forecasting

10.1.5 Company Share Analysis

10.1.6 Benchmarking

10.2 GlobalData Consulting

10.3 Contact Us

10.4 Disclaimer

Table

Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Table 2: Glucose Monitoring Market, North America, Revenue ($m), USD Constant, 2018-2033

Table 3: Glucose Monitoring Market, North America, Volume (Units), 2018-2033

Table 4: Glucose Monitoring Market, North America, Volume (Units), 2018-2033

Table 5: Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2025

Table 6: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 7: Continuous Glucose Monitors Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 8: Glucose Monitoring Market, Canada, Volume (Units), 2018-2033

Table 9: Continuous Glucose Monitors Market, Canada, Volume (Units), 2018-2033

Table 10: Glucose Monitoring Market, Canada, Average Price ($), 2018-2033

Table 11: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2025

Table 12: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 13: Continuous Glucose Monitors Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 14: Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033

Table 15: Continuous Glucose Monitors Market, Mexico, Volume (Units), 2018-2033

Table 16: Glucose Monitoring Market, Mexico, Average Price ($), 2018-2033

Table 17: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2025

Table 18: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 19: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 20: Glucose Monitoring Market, United States, Volume (Units), 2018-2033

Table 21: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033

Table 22: Glucose Monitoring Market, United States, Average Price ($), 2018-2033

Table 23: Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025

Table 24: Glucose Monitoring Market Pipeline Products

Figures

Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Figure 2: Glucose Monitoring Market, North America, Revenue ($m), USD Constant, 2018-2033

Figure 3: Glucose Monitoring Market, North America, Volume (Units), 2018-2033

Figure 4: Glucose Monitoring Market, North America, Volume (Units), 2018-2033

Figure 5: Glucose Monitoring Market, North America, Company Share (%), 2025

Figure 6: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 7: Continuous Glucose Monitors Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 8: Glucose Monitoring Market, Canada, Volume (Units), 2018-2033

Figure 9: Continuous Glucose Monitors Market, Canada, Volume (Units), 2018-2033

Figure 10: Glucose Monitoring Market, Canada, Company Share (%), 2025

Figure 11: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 12: Continuous Glucose Monitors Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 13: Glucose Monitoring Market, Mexico, Volume (Units), 2018-2033

Figure 14: Continuous Glucose Monitors Market, Mexico, Volume (Units), 2018-2033

Figure 15: Glucose Monitoring Market, Mexico, Company Share (%), 2025

Figure 16: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 17: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 18: Glucose Monitoring Market, United States, Volume (Units), 2018-2033

Figure 19: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033

Figure 20: Glucose Monitoring Market, United States, Company Share (%), 2025

North America Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diabetes Care Devices reports

Medical Devices

New

Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors in real time.

Access a live North America Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Glucose Monitoring Market Outlook to 2033 – Continuous Glucose Monitors

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports